isavuconazonium
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The expansion of the immunocompromised patient population including patients with chemotherapy-induced neutropenia and transplant…
On March 6, 2015, the FDA announced approval of isavuconazonium (Cresemba) for treatment of invasive aspergillosis (IA) and…